Abstract:Editorial Office Translational Pediatrics Submitted Jul 15, 2024. Accepted for publication Jul 25, 2024. Published online Aug 28, 2024. doi: 10.21037/tp-2024-02 Erratum to: Transl Pediatr 2023;12:1926-30. The article (1) entitled "Maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients" ( Transl Pediatr 2023;12:1926-30. doi: 10.21037/tp-23-391) unfortunately contained some mistakes in the main text on page 1929. In paragraph 14, the "event-free-survival" should be "overall survival". The OS should be EFS. The data "91%±4.4% (≤2006) versus 88%±4.3% (>2006)" should be "89%±5.1% (≤2006) versus 87%±4.6% (>2006)". The corrected content is presented as below: Survival analyses revealed that there were no significant differences in overall survival after the reassignment being 89%±5.1% (≤2006) versus 94%±3.2% (>2006). The similar trend was observed for EFS showing 89%±5.1% (≤2006) versus 87%±4.6% (>2006). The small increase in OS observed in the group of patients treated >2006 could be due to the better response of a small subset of patients that relapse. The authors apologize for these errors and state that these errors do not change the scientific conclusions of the article in any way. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Correction to: Cystic Fibrosis Revisited - A Review Study

Correction: Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

Correction: Assessing the consistency of iPSC and animal models in cystic fibrosis modelling: A meta-analysis

Correction to: Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019

Correction: Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

Erratum to: Transmission risk of patients with COVID-19 meeting discharge criteria should be interpreted with caution (Journal of Zhejiang University-SCIENCE B, (2020), 21, 5, (408-410), 10.1631/jzus.B2000117)

Erratum: "Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges". Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells and Manuela Funke-Chambour. ERJ Open Res 2022; 8: 00115-2022

Erratum to maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients

Erratum: Carbon Dioxide Level between Nasal High-Frequency Oscillatory Ventilation and Synchronized Nasal Intermittent Positive Pressure Ventilation after Extubation in Neonates: A Cross-over Randomized Controlled Trial

Corrigendum to: Chloro-s-triazenes-toxicokinetic, Toxicodynamic, Human Exposure, and Regulatory Considerations

Erratum: Towards improved 3D reconstruction of cystoscopies through real-time feedback for frame reacquisition: erratum

Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database [Corrigendum]

Correction: Myeloid Heterogeneity Mediates Acute Exacerbations of Pulmonary Fibrosis

Erratum: KCNQ2 Encephalopathy and Responsiveness to Pyridoxal-5′-Phosphate

Correction: De Sanctis et al. Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event. Cancers 2024, 16, 2630

Author Correction: Design, execution, and analysis of CRISPR–Cas9-based deletions and genetic interaction networks in the fungal pathogen Candida albicans

Correction Notice: Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Errors in Key Points and Abstract

Erratum to : Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization

Erratum: The Neutrophil/Lymphocyte Ratio Could Predict Noninvasive Mechanical Ventilation Failure in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study [Corrigendum]